Ondansetron (as Ondansetron HCl Dihydrate): 8mg/4ml
Solution for injection
Prevention Of Nausea And Vomiting Associated With Initial And Repeat Courses Of Emetogenic
Cancer Chemotherapy (It is approved for patients aged 6 months and older)
Prevention Of Postoperative Nausea And/Or Vomiting (It is approved for patients aged 1 month and older)